Bfsg LLC Sells 1,558 Shares of Colgate-Palmolive (NYSE:CL)

Bfsg LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 1.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 86,543 shares of the company’s stock after selling 1,558 shares during the quarter. Colgate-Palmolive comprises approximately 1.0% of Bfsg LLC’s investment portfolio, making the stock its 25th biggest holding. Bfsg LLC’s holdings in Colgate-Palmolive were worth $6,898,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CL. FMR LLC raised its holdings in Colgate-Palmolive by 27.3% during the third quarter. FMR LLC now owns 5,597,742 shares of the company’s stock worth $398,055,000 after acquiring an additional 1,199,660 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc acquired a new position in Colgate-Palmolive during the fourth quarter worth $62,728,000. Assenagon Asset Management S.A. raised its position in Colgate-Palmolive by 92.2% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,436,054 shares of the company’s stock worth $114,468,000 after acquiring an additional 688,733 shares in the last quarter. Envestnet Asset Management Inc. lifted its stake in Colgate-Palmolive by 225.4% in the third quarter. Envestnet Asset Management Inc. now owns 930,072 shares of the company’s stock valued at $66,137,000 after acquiring an additional 644,205 shares during the last quarter. Finally, Bank of Nova Scotia lifted its stake in Colgate-Palmolive by 188.5% in the third quarter. Bank of Nova Scotia now owns 883,272 shares of the company’s stock valued at $62,809,000 after acquiring an additional 577,114 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares of the company’s stock, valued at $1,628,484. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares in the company, valued at $1,628,484. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 61,633 shares of Colgate-Palmolive stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now directly owns 57,948 shares in the company, valued at $4,863,575.64. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock valued at $19,505,099 over the last quarter. 0.34% of the stock is owned by corporate insiders.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Morgan Stanley lifted their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research report on Monday, January 29th. UBS Group increased their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Wells Fargo & Company boosted their price objective on Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a report on Monday, January 29th. Evercore ISI upped their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. Finally, StockNews.com cut Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Stock Up 0.2 %

Colgate-Palmolive stock traded up $0.17 on Thursday, hitting $89.04. 2,040,997 shares of the stock traded hands, compared to its average volume of 4,514,745. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $90.37. The firm has a market cap of $73.19 billion, a P/E ratio of 31.97, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The business’s fifty day simple moving average is $87.40 and its 200 day simple moving average is $81.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $4.95 billion during the quarter, compared to analyst estimates of $4.89 billion. During the same period in the previous year, the business posted $0.77 earnings per share. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.25%. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 71.94%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.